Zeitschrift für Zelluläre und Molekulare Pharmakologie

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

The International Society for Immunopharmacology's Invitation to Join

Gregor Mendel* and Dmitri Mendeleev

The field of immunopharmacology is rapidly evolving, with significant advancements in understanding the complex interactions between drugs and the immune system. The International Society for Immunopharmacology (ISI) has emerged as a leading global platform for scientists and researchers in this field, fostering collaboration, knowledge sharing, and the advancement of immunopharmacology research. This dissertation explores the invitation to join the ISI and its potential benefits for researchers and institutions, as well as the contributions of the society to the field of immunopharmacology. It delves into the resources, networking opportunities, conferences, and scientific publications provided by the ISI, highlighting the potential impact on individual researchers, institutions, and the field as a whole. The dissertation also examines the significance of joining the ISI in terms of global research collaborations, interdisciplinary approaches, and the dissemination of research findings. Through a comprehensive analysis of the invitation to join the ISI, this dissertation aims to provide insights into the advantages and opportunities associated with becoming a part of this esteemed international society.